It seems like AI has taken over the world since ChatGPT launched, but if that’s the case why are so many basic things still manual and painful in the industry?
Chetan will discuss the key characteristics you should look for when screening AI coworkers, something most products are missing. He’ll then show how Rhizome resolves these challenges in the context of regulatory strategy and intelligence work.
Rhizome helps biotech and medtech teams know what their regulator thinks. We help >25 companies research questions across the FDA, EMA, and 8 other regulators. Folks use us to design clinical trials, prepare for regulator interactions, do competitive intel research, and more.
Featured Speaker: Chetan Mishra is the founder of Rhizome AI. He’s building an AI coworker for life sciences – and its initial focus is in reg and clinical research. He was last running the software team for EvolutionaryScale, a drug discovery company acquired by the Chan Zuckerberg Initiative.
